Related Experiment Videos

[Ulcerative colitis]

E Chávez1, S Ceresa, M Rossel

  • 1Unidad de Gastroenterología, Hospital Clínico San Borja-Arriarán.

Insights

This study presents two pediatric cases of ulcerative colitis in Chile, a condition rarely documented there. Both children responded well to salazosulfapyridine treatment, indicating a viable therapeutic option.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research

Background:

  • Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) with limited documented cases in Chilean children.
  • This study addresses the infrequent reporting of pediatric UC within the Chilean context.

Observation:

  • Two pediatric patients, a 14-year-old girl and a 10-year-old boy, presented with prolonged diarrhea, bloody stools, weight loss, anemia, and abdominal pain.
  • Diagnostic evaluations included negative stool analyses for pathogens, barium enema revealing mucosal ulceration, rectosigmoidoscopy showing mucosal inflammation and erosions, and histological confirmation of crypt abscesses and lamina propria inflammation.

Findings:

  • The diagnostic findings confirmed ulcerative colitis in both pediatric patients.
  • Both cases demonstrated a satisfactory therapeutic response to salazosulfapyridine treatment.

Implications:

  • Highlights the occurrence of ulcerative colitis in Chilean children, expanding the understanding of its geographical distribution.
  • Suggests salazosulfapyridine as an effective treatment for pediatric ulcerative colitis in this population.
  • Emphasizes the importance of considering and diagnosing UC in children presenting with relevant gastrointestinal symptoms, even in regions with limited prior reports.

Related Concept Videos